Clearside Biomedical, Inc. (CLSD) Social Stream



Clearside Biomedical, Inc. (CLSD): $1.49

0.16 (+12.03%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

CLEARSIDE BIOMEDICAL INC (CLSD) Price Targets From Analysts

Use the tables below to see what analysts covering CLEARSIDE BIOMEDICAL INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-24 5 $19 $5 $12 $1.03 1065.05%
2021-12-22 5 $17 $5 $10.4 $1.03 909.71%
2022-03-11 4 $17 $7 $10.8 $1.03 948.54%
2022-05-12 5 $17 $7 $10.8 $1.03 948.54%
2022-08-09 3 $11 $7 $9.25 $1.03 798.06%
2022-08-10 3 $11 $5 $8 $1.03 676.7%
2022-11-10 4 $11 $5 $7.2 $1.03 599.03%
2023-02-03 4 $8 $5 $6.25 $1.03 506.8%
2023-03-10 5 $8 $5 $6 $1.03 482.52%
2023-07-10 5 $8 $4 $5.8 $1.03 463.11%
2023-11-14 5 $8 $4 $5.6 $1.03 443.69%

The Trend in the Analyst Price Target


CLSD's average price target has moved down $0.15 over the prior 42 months.

CLSD reports an average of 423.92% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-01 5 8 4 5.8 1.120 417.86%
2023-07-10 5 8 4 5.8 1.060 447.17%
2023-08-15 5 8 4 5.6 0.990 465.66%
2023-11-02 5 8 4 5.6 0.800 600%
2023-11-14 5 8 4 5.6 0.949 490.09%

CLSD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 4 1 0 0 0 5

The Trend in the Broker Recommendations


CLSD's average broker recommendation rating improved by 1 over the prior 43 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CLSD as an investment opportunity.

  • In terms of how CLEARSIDE BIOMEDICAL INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1235.46% of that group.
  • CLEARSIDE BIOMEDICAL INC's average analyst price target is higher than 109.91% of all US stocks.
  • CLEARSIDE BIOMEDICAL INC's number of analysts covering the stock is greater than 254.14% of Healthcare stocks.
  • In terms of how CLEARSIDE BIOMEDICAL INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -826.09% of that group.

Stocks similar to CLEARSIDE BIOMEDICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CRVS, SNDX, and MRKR.

Make investment decisions regarding CLSD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!